• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Seqirus

An artists depiction of an orange chicken pulling what is presumably a large influenza virus particle
Manufacturing

CSL Seqirus picks up its 5th bird-flu-related BARDA award

With a $121.4 million award, the vaccine maker will make enough adjuvant for 40 million vaccine doses.
Zoey Becker Sep 26, 2024 3:50pm
The Top Line

Driving flu vaccine uptake in the post-pandemic era

Aug 30, 2024 8:00am
An artists depiction of an orange chicken pulling what is presumably a large influenza virus particle

Europe taps CSL Seqirus to produce bird flu vaccines

Jun 11, 2024 4:20pm
Seqirus flu vaccine production

UK enlists CSL Seqirus for flu pandemic vaccine preparedness

Sep 26, 2023 10:55am
Arcalis

Japan awarded $115M to Arcturus JV to boost mRNA manufacturing

Aug 14, 2023 11:58am
Paul McKenzie

New CEO Paul McKenzie plots CSL's course for growth

Apr 3, 2023 9:25am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings